Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2003-12-18
2008-11-04
Bunner, Bridget E. (Department: 1647)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S143100, C424S085200, C514S012200
Reexamination Certificate
active
07445779
ABSTRACT:
Provided are cytokines and methods of modulating activity of the immune system using cytokine agonists and antagonists. Also provided are methods of treatment of immune and proliferative disorders.
REFERENCES:
Vitetta et al. Science, Jul. 21, 2006, vol. 313, pp. 308-309.
Immunobiology, Immune System in Health and Disease, Third Edition, Janeway and Travers, Ed., 1997.
Biet, Franck, et al., “Mycobacterium bovis BCG Producing Interleukin-18 Increases Antigen-Specific Gamma Interferon Production in Mice”,Infection and Immunity, 70(12):6549-6557, Dec. 2002.
Bouma, G. and Strober, W., “The Immunological and Genetic Basis of Imflammatory Bowel Disease”,Nature Reviews—Immunology, 3:521-533, Jul. 2003.
Chen, Ling, et al., “Eradication of Murine Bladder Carcinoma by Intratumor Injection of a Bicistronic Adenoviral Vector Carrying cDNAs for the IL-12 Heterodimer and Its Inhibition by the IL-12 p40 Subunit Homodimer”,The Journal of Immunology, 159:351-359, 1997.
Dinarello, Charles A., “Interleukin-18”,Methods, 19:121-132, 1999.
Dorman, S. E., and Holland, S.M., “Interferon-γ and interleukin-12 pathway defects and human disease”,Cytokine&Growth Factor Reviews11:321-333, 2000.
Hong, Kenneth, et al., “Persistence of Pathogenic CD430Th1-Like Cells In Vivo in the Absence of IL-12 but in the Presence of Autoantigen”,The Journal of Immunology, 166:4765-4772, 2001.
Lee, Natalie C., et al., “Production of interferon-gamma by tumor-sensitized T cells is essential for interleukin-12-induced complete tumor eradication”,Surgery, 132(2): 365-368, Aug. 2002.
Lenzi, Renato, et al., “Phase I Study of Intraperitoneal Recombinant Human Interleukin 12 in Patients with Müllerian Carcinoma, Gastrointestinal Primary Malignancies, and Mesothelioma”,Clinical Cancer Research, 8:3686-3695, Dec. 2002.
Marshall, Jason D., et al., “The Interleukin-12-Mediated Pathway of Immune Events Is Dysfunctional in Human Immunodeficiency Virus-Infected Individuals”,Blood, 94(3):1003-1011, Aug. 1, 1999.
Nakanishi, Kenji, et al., “Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu”,Cytokine and Growth Factor Reviews, 12:53-72, 2001.
Neighbors, Margaret, et al., “A Critical Role for Interleukin 18 in Primary and Memory Effector Responses to Listeria Monocytogenes that Extends Beyond its Effects on Interferon γ Production”,J. Exp. Med., 194(3):343-354, Aug. 6, 2001.
Oikawa, Yoichi, et al., “Systemic Administration of IL-18 Promotes Diabetes Development in Young Nonobese Diabetic Mice”,The Journal of Immunology, 171:5865-5875, 2003.
Padigel, Udaikumar M., et al., “The Development of a Th1-Type Response and Resistance to Leishmania major Infection in the Absence of CD40-CD40L Costimulation”,The Journal of Immunology, 167:5874-5879, 2001.
Pien, Gary C., et al., “Cutting Edge: Selective IL-18 Requirements for Induction of Compartmental IFN-γ Responses During Viral Infection”,The Journal of Immunology, 165:4787-4791, 2000.
Pflanz, Stefan, et al., “IL-27, a Heterodimeric Cytokine Composed of EBI3 and p28 Protein, Induces Proliferation of Naïve CD4+T Cells”,Immunity, 16:779-790, Jun. 2002.
Nieuwenhuis, Edward E. S., et al., “Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice”,PNAS, 99(26):16951-16956, Dec. 24, 2002.
Riffault, S. et al., “Transient IFN-γ in the lymph node draining a dermal site loaded with UV-irradiated herpes simplex virus type 1: an NK- and CD3-dependent process regulated by IL-12 but not by IFN-αlβ”,Journal of General Virology, 81:2365-2373, 2000.
Robinson, Douglas S., et al., “Further Checkpoints in Th1 Development”,Immunity, 16:755-758, Jun. 2002.
Rönnblom, L. and Alm, G., “The Natural Interferon-α Producing Cells in Systemic Lupus Erythematosus”,Human Immunology, 63:1181-1193, 2002.
Steinman, Lawrence, “Immunotherapy of multiple sclerosis: the end of the beginning”,Current Opinion in Immunology, 13:597-600, 2001.
Tannenbaum, C. and Hamilton, T., “Immune-inflammatory mechanisms in IFNγ-mediated anti-tumor activity”,Cancer Biology, 10:113-123, 2000.
Varga, Eva Maria, et al., “T Cells from Human Allergen-Induced Last Asthmatic Responses Express IL-12 Receptor βSubunit mRNA and Respond to IL-12 In Vitro”,The Journal of Immunology, 165:2877-2885, 2000.
Wei, Xiao-qing, et al., “Reduced incidence and Severity of Collagen-Induced Arthritis in Mice Lacking IL-18”,The Journal of Immunology, 166:517-521, 2001.
De Waal Malefyt Rene
Travis Marilyn
Vaisberg Elena
Bunner Bridget E.
Hamud Fozia M
Schering Corporation
LandOfFree
Methods of modulating IFNy production does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of modulating IFNy production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of modulating IFNy production will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4022752